Snowden Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Buy
61,296
+30,302
+98% +$975K 0.05% 355
2025
Q4
$967K Sell
30,994
-7,358
-19% -$181K 0.03% 539
2025
Q3
$775K Sell
38,352
-1,241
-3% -$21.8K 0.02% 605
2025
Q2
$664K Buy
39,593
+3,710
+10% +$59.9K 0.02% 655
2025
Q1
$552K Buy
35,883
+3,320
+10% +$59.3K 0.02% 698
2024
Q4
$718K Sell
32,563
-4,350
-12% -$79.1K 0.02% 624
2024
Q3
$665K Buy
36,913
+5,285
+17% +$92.5K 0.02% 647
2024
Q2
$514K Sell
31,628
-1,568
-5% -$24.2K 0.02% 737
2024
Q1
$468K Buy
33,196
+4,124
+14% +$52K 0.01% 788
2023
Q4
$304K Buy
29,072
+129
+0.4% +$1.2K 0.01% 900
2023
Q3
$295K Buy
28,943
+18,587
+179% +$173K 0.01% 866
2023
Q2
$78K Buy
+10,356
New +$84K ﹤0.01% 1147
2022
Q1
Sell
-41
Closed 1965
2021
Q4
$0 Buy
+41
New +$370 ﹤0.01% 2153

Other funds holding TEVA